Biodexa Pharmaceuticals PLC, a clinical stage biopharmaceutical company, announced the appointment of Ann Merchant as a Non-executive Director to its Board of Directors, effective December 31, 2023. Merchant brings extensive experience from her current role as Vice President and Head of Global Supply Chain and External Operations at MorphoSys AG, and her previous position as President of Schreiner Medipharm. She has also held various roles at Amgen Inc., including Vice President and Head of International Supply Chain. Merchant, who holds an MBA from Henley Business School and a Bachelor of Science from Georgetown University, is also on the board of Alvotech S.A. Her term as a director at Biodexa Pharmaceuticals is set to expire at the company's annual general...Show More

Biodexa Pharmaceuticals PLC, a clinical stage biopharmaceutical company, announced the appointment of Ann Merchant as a Non-executive Director to its Board of Directors, effective December 31, 2023. Merchant brings extensive experience from her current role as Vice President and Head of Global Supply Chain and External Operations at MorphoSys AG, and her previous position as President of Schreiner Medipharm. She has also held various roles at Amgen Inc., including Vice President and Head of International Supply Chain. Merchant, who holds an MBA from Henley Business School and a Bachelor of Science from Georgetown University, is also on the board of Alvotech S.A. Her term as a director at Biodexa Pharmaceuticals is set to expire at the company's annual general meeting in 2026. In addition to her directorship, Merchant is expected to be granted options to acquire one percent of the company's outstanding ordinary shares and to serve on the audit and remuneration committees. The appointment is part of a Form 6-K filing with the SEC for December 2023, which also includes a press release dated December 29, 2023.